Search results for "cancer diagnosis"
Selected Filters:
Recombinant Human Kita-kyushu lung cancer antigen 1 (CT83), partial, Biotinylated
- Manufacturer
- CUSABIO
- Catalog Number
- CSB-EP711093HU1-B
- Host
- Human
- Applications
- SDS-PAGE, ELISA, Western Blotting, Immunoassay
Rabbit anti-human serologically defined colon cancer antigen 3 polyclonal Antibody
- Manufacturer
- MyBioSource
- Catalog Number
- MBS712684
- Host
- Rabbit
- Reactivity
- Human, Mouse
- Applications
- ELISA, Immunohistochemistry
Rabbit anti-human serologically defined colon cancer antigen 1 polyclonal Antibody
- Manufacturer
- MyBioSource
- Catalog Number
- MBS713103
- Host
- Rabbit
- Reactivity
- Human, Mouse
- Applications
- ELISA, Immunohistochemistry, Western Blotting
Rabbit anti-human breast cancer anti-estrogen resistance 1 polyclonal Antibody
- Manufacturer
- MyBioSource
- Catalog Number
- MBS713871
- Host
- Rabbit
- Reactivity
- Human, Mouse
- Applications
- ELISA, Immunofluorescence, Immunohistochemistry, Western Blotting
Rabbit anti-human serologically defined colon cancer antigen 8 polyclonal Antibody
- Manufacturer
- MyBioSource
- Catalog Number
- MBS714539
- Host
- Rabbit
- Reactivity
- Human, Mouse
- Applications
- ELISA, Immunofluorescence, Western Blotting
Rabbit anti-human serologically defined colon cancer antigen 10 polyclonal Antibody
- Manufacturer
- MyBioSource
- Catalog Number
- MBS714909
- Host
- Rabbit
- Reactivity
- Human, Mouse
- Applications
- ELISA, Western Blotting
Cancer testing readiness on Day One of drug launch – Lessons learnt
Accurate ligand high-affinity determination
Johan Engström, Senior Scientist at Gyros Protein Technologies, discusses the challenges of measuring high-affinity interactions of ligands in cancer immunotherapy
Advancing oncology therapeutics development with 2D & 3D cell screening
Catch up on this expert webinar to discover the customizable screening service helping to drive the validation of novel cancer therapies
Predicting patient response to immunotherapy treatment
Dr. Ofer Sharon discusses a new cancer research platform designed to improve patient outcomes, cut costs, and minimize unnecessary adverse events
BioDot accelerates customer innovation through acquisition by ATS Automation
Integration expands automated, ultra-low volume dispensing capabilities across point-of-care diagnostics, clinical diagnostics and the life sciences, positioning customers for further growth
Roche launches laboratory SARS-CoV-2 antigen test to support high-volume testing of suspected COVID-19 patients
The Elecsys SARS-CoV-2 Antigen test is an automated laboratory assay intended as an aid in the diagnosis of active SARS-CoV-2 infection